Single Dose of Intravenous Ferric Carboxymaltose Prevents Anemia for 6 Months among Moderately or Severely Anemic Postpartum Women: A Case Study from India
Open Access
- 8 July 2021
- journal article
- research article
- Published by Elsevier BV in Current Developments in Nutrition
- Vol. 5 (7), nzab078
- https://doi.org/10.1093/cdn/nzab078
Abstract
The effectiveness of intravenous ferric carboxymaltose (FCM) in quickly increasing normal hemoglobin concentration and replenishing body iron reserves up to 6–12 wk is known; however, its long-term effectiveness is unknown. In this study conducted in northern India during August 2018 to February 2019, 100 postpartum women within 48 h of delivery with a hemoglobin concentration between 5.0 and 9.9 g/dL were included. A single dose of intravenous FCM was administered. The hemoglobin and serum ferritin concentrations were measured at baseline and at 6 mo. Out of 100 women recruited, 57 (57%) returned for the follow-up visit at 6 mo. The mean (± SD) hemoglobin and serum ferritin concentrations at baseline were 8.6 ± 1.1 g/dL and 15.8 ± 17.2 ng/mL, respectively, and at 6 months were 12.5 ± 1.2 g/dL and 72.0 ± 52.0 ng/mL, respectively. The mean increase in hemoglobin concentration was 3.9 (95% CI: 3.5, 4.3) g/dL (P < 0.001) and for serum ferritin was 53.8 (95% CI: 41.8, 65.8) ng/mL (P < 0.001). The study was registered prospectively in the Clinical Trials Registry–India (CTRI) as CTRI/2018/06/014332.Keywords
This publication has 11 references indexed in Scilit:
- Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trialThe Lancet. Global Health, 2020
- Comparative Study of Efficacy and Safety of Ferric Carboxymaltose Versus Iron Sucrose in Post-partum AnaemiaThe Journal of Obstetrics and Gynecology of India, 2017
- IV Ferric Carboxymaltose Vs Oral Iron in the Treatment of Post-partum Iron Deficiency AnaemiaJournal of Clinical and Diagnostic Research, 2016
- Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: A pilot studyInternational Journal of Cardiology, 2014
- Long-Term Efficacy of Postpartum Intravenous Iron TherapyBioMed Research International, 2014
- Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial dataBMC Blood Disorders, 2011
- Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trialAmerican Journal of Obstetrics and Gynecology, 2008
- Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemiaInternational Journal of Gynecology & Obstetrics, 2008
- Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Postpartum AnemiaObstetrics & Gynecology, 2007